Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ATP-dependent activity	MYO7A ABCA7 ACSL4 MDN1 MOV10L1 DNAH5 DNAH8 DDX11L8 SLC27A3 RAD51D HYOU1 MYO19 CHD7 DMC1 CHTF18 DNAH17 MACF1 CDC6	4.85e-05	614	200	18	GO:0140657
GeneOntologyCellularComponent	outer dynein arm	DNAH5 DNAH8 DNAH17	1.94e-04	12	206	3	GO:0036157
GeneOntologyCellularComponent	cytoplasmic region	ZC3H14 CLASP2 DNAH5 DNAH8 RSPH10B HAP1 WDPCP WDR11 DNAH17 RIMS1 TRAK2 CTNNB1	2.51e-04	360	206	12	GO:0099568
GeneOntologyCellularComponent	ficolin-1-rich granule membrane	SIRPA ITGAX DSG1 DSP NCKAP1L	3.36e-04	61	206	5	GO:0101003
GeneOntologyCellularComponent	site of DNA damage	PARP9 PELI1 APLF DMC1 RIF1 SLF2 TP53BP1	4.25e-04	137	206	7	GO:0090734
GeneOntologyCellularComponent	site of double-strand break	PELI1 APLF DMC1 RIF1 SLF2 TP53BP1	4.96e-04	101	206	6	GO:0035861
MousePheno	postnatal lethality, incomplete penetrance	ASXL1 ZNF148 MAP1B CYP7A1 TAB2 DNAJC6 SCNN1G KIT MGRN1 FLNA SELENOP HAP1 FOXN4 NTF3 POLR2A CHD7 GRIN1 RIF1 TIA1 TIAL1 LMO7 ZFHX3	5.07e-06	669	156	22	MP:0011086
MousePheno	lethality during fetal growth through weaning, incomplete penetrance	ASXL1 ZNF148 MAP1B CYP7A1 TNRC6B MECOM TAB2 DNAJC6 F5 SCNN1G KMT2A KIT DNAH5 MN1 MGRN1 FLNA SELENOP HAP1 FOXN4 NTF3 POLR2A CHD7 GRIN1 SCYL2 RIF1 TIA1 TIAL1 WDR11 LMO7 ZFHX3	5.87e-06	1124	156	30	MP:0011112
MousePheno	reduced fertility	ZC3H14 GALT MAP1B MYO7A MECOM ACSL4 KMT2A KIT MGRN1 FLNA SELENOP ARID4A ACBD5 APOB CHD7 GRIN1 NCOA5 ZP1 DMC1 RIF1 WDR11 CHTF18 DNAH17 CTNNB1 TP53BP1	6.82e-06	844	156	25	MP:0001921
Domain	AAA	ABCA7 MDN1 DNAH5 DNAH8 RAD51D DMC1 CHTF18 CDC6	1.37e-04	144	195	8	SM00382
Domain	AAA+_ATPase	ABCA7 MDN1 DNAH5 DNAH8 RAD51D DMC1 CHTF18 CDC6	1.37e-04	144	195	8	IPR003593
Domain	EGF_CA	TPO VWA2 NOTCH1 FBLN5 CRTAC1 EDIL3 SNED1	2.96e-04	122	195	7	SM00179
Domain	RNA_pol_Rpb1_2	POLR1A POLR2A	3.23e-04	3	195	2	PF00623
Domain	RNA_pol_asu	POLR1A POLR2A	3.23e-04	3	195	2	IPR000722
Domain	RNA_pol_N	POLR1A POLR2A	3.23e-04	3	195	2	IPR006592
Domain	Latrophilin	ADGRL2 ADGRL3	3.23e-04	3	195	2	PF02354
Domain	RNA_pol_Rpb1_1	POLR1A POLR2A	3.23e-04	3	195	2	PF04997
Domain	RNA_pol_Rpb1_5	POLR1A POLR2A	3.23e-04	3	195	2	PF04998
Domain	RNA_pol_Rpb1_3	POLR1A POLR2A	3.23e-04	3	195	2	PF04983
Domain	RNA_pol_Rpb1_4	POLR1A POLR2A	3.23e-04	3	195	2	PF05000
Domain	HAP1_N	HAP1 TRAK2	3.23e-04	3	195	2	IPR006933
Domain	RPOLA_N	POLR1A POLR2A	3.23e-04	3	195	2	SM00663
Domain	RNA_pol_Rpb1_4	POLR1A POLR2A	3.23e-04	3	195	2	IPR007083
Domain	RNA_pol_Rpb1_5	POLR1A POLR2A	3.23e-04	3	195	2	IPR007081
Domain	RNA_pol_Rpb1_1	POLR1A POLR2A	3.23e-04	3	195	2	IPR007080
Domain	RNA_pol_Rpb1_3	POLR1A POLR2A	3.23e-04	3	195	2	IPR007066
Domain	-	RASA4B RASA4	3.23e-04	3	195	2	4.10.1130.10
Domain	UPF0560	FAM171B FAM171A2	3.23e-04	3	195	2	PF10577
Domain	Uncharacterised_FAM171	FAM171B FAM171A2	3.23e-04	3	195	2	IPR018890
Domain	HAP1_N	HAP1 TRAK2	3.23e-04	3	195	2	PF04849
Domain	GPCR_2_latrophilin_rcpt_C	ADGRL2 ADGRL3	3.23e-04	3	195	2	IPR003334
Domain	EGF-like_Ca-bd_dom	TPO VWA2 NOTCH1 FBLN5 CRTAC1 EDIL3 SNED1	3.27e-04	124	195	7	IPR001881
Domain	ATPase_dyneun-rel_AAA	MDN1 DNAH5 DNAH8	3.75e-04	14	195	3	IPR011704
Domain	AAA_5	MDN1 DNAH5 DNAH8	3.75e-04	14	195	3	PF07728
Domain	EGF_Ca-bd_CS	TPO NOTCH1 FBLN5 CRTAC1 EDIL3 SNED1	5.39e-04	97	195	6	IPR018097
Domain	CH	SPTBN1 CNN1 FLNA LMO7 MACF1	5.86e-04	65	195	5	SM00033
Domain	EGF_CA	TPO NOTCH1 FBLN5 CRTAC1 EDIL3 SNED1	6.01e-04	99	195	6	PS01187
Domain	RasGAP_dom	RASA4B PLXNB1 RASA4	8.15e-04	18	195	3	IPR001936
Domain	CH	SPTBN1 CNN1 FLNA LMO7 MACF1	8.23e-04	70	195	5	PF00307
Domain	-	SPTBN1 CNN1 FLNA LMO7 MACF1	8.78e-04	71	195	5	1.10.418.10
Domain	CH	SPTBN1 CNN1 FLNA LMO7 MACF1	9.96e-04	73	195	5	PS50021
Domain	Gal_Lectin	ADGRL2 ADGRL3	1.06e-03	5	195	2	PF02140
Domain	GPCR_2_latrophilin	ADGRL2 ADGRL3	1.06e-03	5	195	2	IPR003924
Domain	Lectin_gal-bd_dom	ADGRL2 ADGRL3	1.06e-03	5	195	2	IPR000922
Domain	SUEL_LECTIN	ADGRL2 ADGRL3	1.06e-03	5	195	2	PS50228
Domain	CH-domain	SPTBN1 CNN1 FLNA LMO7 MACF1	1.13e-03	75	195	5	IPR001715
Domain	FG_GAP	ITGAX ITFG1 CRTAC1	1.49e-03	22	195	3	PS51470
Domain	-	DSP MACF1	1.58e-03	6	195	2	3.90.1290.10
Domain	Rad51_DMC1_RadA	RAD51D DMC1	1.58e-03	6	195	2	IPR033925
Domain	DNA_recomb/repair_RecA-like	RAD51D DMC1	1.58e-03	6	195	2	IPR016467
Domain	ACTININ_2	SPTBN1 FLNA MACF1	1.70e-03	23	195	3	PS00020
Domain	ACTININ_1	SPTBN1 FLNA MACF1	1.70e-03	23	195	3	PS00019
Domain	Actinin_actin-bd_CS	SPTBN1 FLNA MACF1	1.70e-03	23	195	3	IPR001589
Domain	PH_dom-like	MYO7A SPTBN1 PLEKHS1 TYK2 ARHGAP22 TBC1D1 PLEKHA5 RASA4B PARP9 FRMPD1 RASA4 PLEKHM3	1.79e-03	426	195	12	IPR011993
Domain	FG-GAP	ITGAX ITFG1 CRTAC1	1.93e-03	24	195	3	PF01839
Domain	FG-GAP	ITGAX ITFG1 CRTAC1	1.93e-03	24	195	3	IPR013517
Domain	Cadherin_C	CDH20 DSG1 CDH4	2.18e-03	25	195	3	PF01049
Domain	Cadherin_cytoplasmic-dom	CDH20 DSG1 CDH4	2.18e-03	25	195	3	IPR000233
Domain	DNA_recomb/repair_Rad51_C	RAD51D DMC1	2.20e-03	7	195	2	IPR013632
Domain	RecA_ATP-bd	RAD51D DMC1	2.20e-03	7	195	2	IPR020588
Domain	RECA_2	RAD51D DMC1	2.20e-03	7	195	2	PS50162
Domain	Plectin	DSP MACF1	2.20e-03	7	195	2	PF00681
Domain	Plectin_repeat	DSP MACF1	2.20e-03	7	195	2	IPR001101
Domain	Rad51	RAD51D DMC1	2.20e-03	7	195	2	PF08423
Domain	PLEC	DSP MACF1	2.20e-03	7	195	2	SM00250
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	ZNF148 RBM10 SPTBN1 TATDN2 MDN1 NAF1 KMT2A MN1 FLNA GCFC2 ARID4A DSP POLR2A RALGAPB CHD7 RIF1 KANSL1 LMO7 CHTF18 RBM7 RIMS1 SRRM2 TP53BP1	3.05e-10	774	207	23	15302935
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	ZC3H14 MAP1B SPTBN1 MDN1 KMT2A NUP160 FLNA HYOU1 POLR1A DSP POLR2A BEND3 CHD7 RIF1 CSE1L MACF1 AATF EIF3D SRRM2 TP53BP1	2.82e-09	653	207	20	22586326
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ASXL1 RAPGEF5 RBM10 TNRC6B DNAJC6 TBC1D1 ADGRL3 FRMPD1 RALGAPB BEND3 R3HDM2 KANSL1 MACF1 TRAK2 SRRM2 PDZD2	3.62e-09	407	207	16	12693553
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	MAP1B CEP85L SPTBN1 TAB2 CLASP2 LUZP1 MDN1 MAST4 TBC1D1 KMT2A PLEKHA5 DSP RALGAPB STIL FAM171A2 SLF2 LMO7 DYRK1B RBM7 MACF1 PLEKHM3 SRRM2	1.18e-08	861	207	22	36931259
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	ZC3H14 MAP1B RBM10 MDH2 F5 MDN1 NUP160 FLNA HYOU1 POLR1A DSG1 DSP POLR2A EDIL3 NCOA5 RIF1 CSE1L TIAL1 LMO7 MACF1 AATF EIF3D CTNNB1 SRRM2	1.28e-08	1024	207	24	24711643
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	SPTBN1 TAB2 CLASP2 SGO1 LUZP1 ACSL4 ADGRL2 NOTCH1 HYOU1 VEZT DSP POLR2A RALGAPB ACBD5 FAM171B NCOA5 RIF1 CSE1L FAM171A2 WDR11 AATF SRRM2 SLC29A1 FBXW7	2.03e-08	1049	207	24	27880917
Pubmed	MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development.	ZC3H14 MAP1B MYO7A NOTCH1 TOM1L2 WWP1 POLR2A CHD7 STIL TIAL1 MACF1 CTNNB1 SRRM2 CDH4	3.77e-08	358	207	14	32460013
Pubmed	Combination of KIR and HLA gene variants augments the risk of developing birdshot chorioretinopathy in HLA-A*29-positive individuals.	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	1.50e-07	9	207	4	18340360
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	RBM10 TNRC6B MECOM ARHGAP22 NOTCH1 DSG1 DSP BEND3 STIL SCYL2	1.75e-07	184	207	10	32908313
Pubmed	FAM83D knockdown regulates proliferation, migration and invasion of colorectal cancer through inhibiting FBXW7/Notch-1 signalling pathway.	FAM83D NOTCH1 FBXW7	2.08e-07	3	207	3	28407575
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	ZC3H14 ZNF148 MAP1B RBM10 TNRC6B LUZP1 KMT2A PLEKHA5 FLNA DSP POLR2A BEND3 SCYL2 LMO7 WIPI2 TP53BP1	2.25e-07	549	207	16	38280479
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	ASXL1 ZNF148 MAP1B MECOM ACSL4 TRAPPC13 MDN1 ADGRL2 KIT NUP160 NOTCH1 ARID4A DSP POLR2A FRMPD1 BEND3 RIF1 KANSL1 CTNNB1 TP53BP1	2.41e-07	857	207	20	25609649
Pubmed	[Genotype analysis of killer cell immunoglobulin-like receptors in Graves' disease patients].	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	3.89e-07	11	207	4	19664392
Pubmed	Human transcription factor protein interaction networks.	ASXL1 ZNF148 RBM10 SPTBN1 TNRC6B MECOM KMT2A DET1 ARID4A BEND3 R3HDM2 CHD7 RIF1 MIDN CSE1L KANSL1 RLIM NCOA1 MRPS34 ZFHX3 EIF3D HAL TBR1 SRRM2 TP53BP1 FBXW7	4.50e-07	1429	207	26	35140242
Pubmed	The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation.	ZNF148 RBM10 SPTBN1 ARHGAP22 NUP160 FLNA ARID4A DSP POLR2A BEND3 CHD7 RIF1 DYRK1B ZFHX3 EIF3D TP53BP1	4.99e-07	583	207	16	29844126
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	MAP1B SPTBN1 LUZP1 ACSL4 MDN1 PLEKHA5 NUP160 FLNA POLR1A DSG1 DSP MYO19 POLR2A CHD7 RIF1 CSE1L KANSL1 WDR11 CHTF18 RBM7 MACF1 AATF EIF3D SRRM2 TP53BP1	5.77e-07	1353	207	25	29467282
Pubmed	Distribution of killer cell immunoglobulin-like receptors (KIR) and their HLA-C ligands in two Iranian populations.	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	5.81e-07	12	207	4	19936734
Pubmed	Association of killer cell immunoglobulin-like receptors with primary Sjogren's syndrome.	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	5.81e-07	12	207	4	19181658
Pubmed	[Relationship between CMV reactivation and KIR haplotype/HLA-Cw genotype in patients after unrelated-donor hematopoietic stem cell transplantation.].	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	5.81e-07	12	207	4	20137308
Pubmed	Association of killer cell immunoglobulin-like receptor 2DL5 with systemic lupus erythematosus and accompanying infections.	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	5.81e-07	12	207	4	20371502
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	RAPGEF5 SPTBN1 TAB2 CLASP2 MKLN1 PLXNB1 TOM1L2 FLNA HYOU1 WWP1 FRMPD1 NFKBIZ APOB CHD7 FAM171B TIA1 RLIM MACF1 AATF SLC29A1 TP53BP1 NCKAP1L	6.24e-07	1084	207	22	11544199
Pubmed	KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma.	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	8.36e-07	13	207	4	19934297
Pubmed	Different KIRs confer susceptibility and protection to adults with latent autoimmune diabetes in Latvian and Asian Indian populations.	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	8.36e-07	13	207	4	19120281
Pubmed	[Study on the polymorphism of killer cell immunoglobulin like receptor (KIR) gene with systemic lupus erythematosus of North population in China].	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	8.36e-07	13	207	4	18687225
Pubmed	Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome.	THSD4 MAP1B SPTBN1 MDN1 FLNA POLR1A DSP POLR2A OGDH CSE1L	8.66e-07	219	207	10	31353912
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	ASXL1 TNRC6B TAB2 TBC1D1 PLEKHA5 RALGAPB CHD7 LMO7 MACF1 UNC80	1.11e-06	225	207	10	12168954
Pubmed	Frequencies of killer immunoglobulin-like receptor genotypes influence susceptibility to spontaneous abortion.	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	1.16e-06	14	207	4	19875891
Pubmed	Multiple sclerosis associates with LILRA3 deletion in Spanish patients.	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	1.16e-06	14	207	4	19421224
Pubmed	Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia.	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	1.16e-06	14	207	4	18945962
Pubmed	[Genotype and haplotype analysis of killer cell immunoglobulin-like receptors in ankylosing spondylitis].	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	1.16e-06	14	207	4	19489269
Pubmed	Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population.	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	1.16e-06	14	207	4	15896204
Pubmed	A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase.	MAP1B RBM10 TATDN2 POLR1A ACBD5 WDR11 AATF EIF3D CTNNB1 FBXW7	1.46e-06	232	207	10	25515538
Pubmed	KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations.	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	1.58e-06	15	207	4	17498266
Pubmed	Killer cell immunoglobulin-like receptor gene diversity in a Caucasian population of southern Brazil.	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	1.58e-06	15	207	4	20082646
Pubmed	Killer cell immunoglobulin-like receptors in HLA-B27-associated acute anterior uveitis, with and without axial spondyloarthropathy.	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	1.58e-06	15	207	4	19850842
Pubmed	[Killer cell immunoglobin-like receptor and its ligand gene polymorphisms in Hunan Han patients with type 1 diabetes].	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	1.58e-06	15	207	4	20356536
Pubmed	Disparate distribution of activating and inhibitory killer cell immunoglobulin-like receptor genes in patients with systemic lupus erythematosus.	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	1.58e-06	15	207	4	19926642
Pubmed	Natural killer-cell receptor polymorphisms and posttransplantation non-Hodgkin lymphoma.	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	1.58e-06	15	207	4	20207982
Pubmed	Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia.	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	1.58e-06	15	207	4	19493232
Pubmed	Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	1.58e-06	15	207	4	20643584
Pubmed	Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	1.58e-06	15	207	4	19326408
Pubmed	A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome.	RBM10 RASA4B KIT DNAH8 POLR2A APOB STIL SCYL2 CSE1L RLIM SRRM2 UNC80 WIPI2	1.63e-06	420	207	13	28065597
Pubmed	Wnt regulation: exploring Axin-Disheveled interactions and defining mechanisms by which the SCF E3 ubiquitin ligase is recruited to the destruction complex.	MAP1B SPTBN1 TAB2 MDH2 AMZ2 MDN1 MKLN1 FLNA DSG1 DSP OGDH NCOA5 CSE1L WDR11 MRPS34 EIF3D CTNNB1 SRRM2	1.94e-06	809	207	18	32129710
Pubmed	Vezatin, a novel transmembrane protein, bridges myosin VIIA to the cadherin-catenins complex.	MYO7A VEZT CTNNB1	2.06e-06	5	207	3	11080149
Pubmed	Diversity of the repertoire of p58 killer cell inhibitory receptors in a single individual.	KIR2DS2 KIR2DS1 KIR2DS4	2.06e-06	5	207	3	10424431
Pubmed	In contrast to other stimulatory natural killer cell immunoglobulin-like receptor loci, several KIR2DS5 alleles predominate in African Americans.	KIR2DS2 KIR2DS1 KIR2DS4	2.06e-06	5	207	3	19410616
Pubmed	Killer cell immunoglobulin-like receptor gene-cluster 3DS1-2DL5-2DS1-2DS5 predisposes susceptibility to Vogt-Koyanagi-Harada syndrome in Japanese individuals.	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	2.10e-06	16	207	4	19897003
Pubmed	Distribution of killer cell immunoglobulin-like receptor (KIR) genotypes in patients with familial Mediterranean fever.	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	2.10e-06	16	207	4	19309280
Pubmed	[Polymorphism of killer cell immunoglobulin-like receptors gene family in Zhejiang Han population].	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	2.10e-06	16	207	4	16403292
Pubmed	Polymorphisms of KIR gene and HLA-C alleles: possible association with susceptibility to HLA-B27-positive patients with ankylosing spondylitis.	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	2.10e-06	16	207	4	20652381
Pubmed	No association of KIR genes with Behcet's disease.	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	2.10e-06	16	207	4	17868255
Pubmed	Report from the killer immunoglobulin-like receptor (KIR) anthropology component of the 15th International Histocompatibility Workshop: worldwide variation in the KIR loci and further evidence for the co-evolution of KIR and HLA.	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	2.10e-06	16	207	4	20331834
Pubmed	Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Java, Kalimantan, Timor and Irian Jaya.	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	2.10e-06	16	207	4	19000141
Pubmed	Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Sumatra, Sulawesi and Moluccas Islands.	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	2.10e-06	16	207	4	20670355
Pubmed	Asian population frequencies and haplotype distribution of killer cell immunoglobulin-like receptor (KIR) genes among Chinese, Malay, and Indian in Singapore.	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	2.10e-06	16	207	4	18668235
Pubmed	Activating killer cell immunoglobulin-like receptor genes' association with recurrent miscarriage.	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	2.10e-06	16	207	4	19527230
Pubmed	Influence of activating and inhibitory killer immunoglobulin-like receptors on predisposition to recurrent miscarriages.	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	2.10e-06	16	207	4	19279038
Pubmed	A study of the killer cell immunoglobulin-like receptor gene KIR2DS1 in a Caucasoid Brazilian population with psoriasis vulgaris.	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	2.10e-06	16	207	4	18643961
Pubmed	HLA-DQA1*0505 sharing and killer immunoglobulin-like receptors in sub fertile couples: report from the 15th International Histocompatibility Workshop.	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	2.10e-06	16	207	4	20210919
Pubmed	[Effects of killer immunoglobulin-like receptor and human leukocyte antigen class I ligand on the prognosis of related donor hematopoietic stem cell transplantation].	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	2.73e-06	17	207	4	19968064
Pubmed	Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection.	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	2.73e-06	17	207	4	20878400
Pubmed	Role of killer cell immunoglobulin-like receptor gene content and human leukocyte antigen-C group in susceptibility to human T-lymphotropic virus 1-associated myelopathy/tropical spastic paraparesis in Peru.	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	2.73e-06	17	207	4	20483367
Pubmed	Killer cell immunoglobulin-like receptor gene polymorphisms in patients with leukemia: possible association with susceptibility to the disease.	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	2.73e-06	17	207	4	19450876
Pubmed	Distribution of killer-cell immunoglobulin-like receptor genes in Eastern mainland Chinese Han and Taiwanese Han populations.	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	2.73e-06	17	207	4	19761533
Pubmed	Killer cell immunoglobulin-like receptor gene diversity in the Tibetan ethnic minority group of China.	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	2.73e-06	17	207	4	20650299
Pubmed	The role of killer immunoglobulin-like receptor haplotypes on the outcome of unrelated donor haematopoietic SCT for thalassaemia.	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	2.73e-06	17	207	4	20173792
Pubmed	[Analysis of natural killer cell immunoglobulin-like receptor genes in Chinese].	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	2.73e-06	17	207	4	19218127
Pubmed	KIR genes and KIR ligands affect occurrence of acute GVHD after unrelated, 12/12 HLA matched, hematopoietic stem cell transplantation.	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	2.73e-06	17	207	4	19169284
Pubmed	Association of killer cell immunoglobulin-like receptors and human leukocyte antigen-C genotypes in South Brazilian with type 1 diabetes.	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	3.49e-06	18	207	4	20580654
Pubmed	Influence of HLA class I and HLA-KIR compound genotypes on HIV-2 infection and markers of disease progression in a Manjako community in West Africa.	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	3.49e-06	18	207	4	20519398
Pubmed	Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection.	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	3.49e-06	18	207	4	19846535
Pubmed	Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	3.49e-06	18	207	4	19630074
Pubmed	Signatures of natural selection and coevolution between killer cell immunoglobulin-like receptors (KIR) and HLA class I genes.	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	3.49e-06	18	207	4	20200544
Pubmed	Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	3.49e-06	18	207	4	19046302
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	ZC3H14 ZNF148 RBM10 PLEKHS1 LUZP1 MDN1 KMT2A POLR1A NCOA5 SCYL2 RIF1 TIA1 TIAL1 LMO7 RBM7 MRPS34 AATF SRRM2	3.67e-06	847	207	18	35850772
Pubmed	Killer cell immunoglobulin-like receptor gene polymorphism in lymphoproliferative diseases of granular lymphocytes in a Japanese population.	KIR2DS2 KIR2DS1 KIR3DL1	4.10e-06	6	207	3	20528243
Pubmed	Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with solid tumors.	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	4.41e-06	19	207	4	20600442
Pubmed	KIR and HLA gene combinations in Vogt-Koyanagi-Harada disease.	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	4.41e-06	19	207	4	18571006
Pubmed	Association between killer-cell immunoglobulin-like receptor genotypes and leprosy in Brazil.	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	4.41e-06	19	207	4	18778326
Pubmed	Killer cell immunoglobulin-like receptor gene diversity in a Southern Brazilian population from the state of Paraná.	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	4.41e-06	19	207	4	18848853
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	ZC3H14 ZNF148 MAP1B RBM10 LUZP1 KMT2A FLNA ARID4A DSP POLR2A BEND3 CHD7 RIF1 TIAL1 SLF2 RBM7 AATF SRRM2 TP53BP1	4.95e-06	954	207	19	36373674
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	TNRC6B CLASP2 LUZP1 MAST4 PLEKHA5 TBC1D8 MACF1 TRAK2 WIPI2	4.97e-06	209	207	9	36779422
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	ZC3H14 ZNF148 LUZP1 AMZ2 KMT2A NUP160 BEND3 NFKBIZ CHD7 CSE1L TIAL1 CTNNB1 TP53BP1	5.43e-06	469	207	13	27634302
Pubmed	HLA and KIR frequencies in Sicilian Centenarians.	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	5.48e-06	20	207	4	20426625
Pubmed	Analysis of Presenilin 1 and 2 interacting proteins in mouse cerebral cortex during development.	MAST4 NOTCH1 GRIN1 CTNNB1	5.48e-06	20	207	4	25196998
Pubmed	Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay.	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	5.48e-06	20	207	4	20193031
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	MAP1B SPTBN1 BIVM ANKRD30B CNPY2 MDH2 SGO1 LUZP1 ACSL4 MDN1 KMT2A DNAH8 FLNA HYOU1 DSP BEND3 APOB PPARA OGDH TIAL1 LMO7 MACF1 AATF RIMS1	5.91e-06	1442	207	24	35575683
Pubmed	Activating killer cell immunoglobulin-like receptors 3DS1 and 2DS1 protect against developing the severe form of recurrent respiratory papillomatosis.	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	6.74e-06	21	207	4	19861144
Pubmed	Activation of a subset of human NK cells upon contact with Plasmodium falciparum-infected erythrocytes.	KIR2DS2 KIR2DS4 KIR3DL1	7.15e-06	7	207	3	14607943
Pubmed	Identification of seventeen novel KIR variants: fourteen of them from two non-Caucasian donors.	KIR2DS2 KIR2DS1 KIR2DS4	7.15e-06	7	207	3	11169255
Pubmed	Mutations in DNAH17, Encoding a Sperm-Specific Axonemal Outer Dynein Arm Heavy Chain, Cause Isolated Male Infertility Due to Asthenozoospermia.	DNAH5 DNAH8 DNAH17	7.15e-06	7	207	3	31178125
Pubmed	Distribution of KIR genes in the population of unrelated individuals homozygous for ancestral haplotype AH8.1 (HLA-A1B8DR3).	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	8.20e-06	22	207	4	20492596
Pubmed	The SOX2-interactome in brain cancer cells identifies the requirement of MSI2 and USP9X for the growth of brain tumor cells.	MECOM MDN1 MKLN1 CHD7 SCYL2 TIA1 TIAL1 RBM7 MACF1 CTNNB1	8.23e-06	282	207	10	23667531
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	SPTBN1 TNRC6B CLASP2 MDH2 LUZP1 ACSL4 ACAD11 NAF1 KMT2A TCEA3 FLNA DSG1 DSP APOB CHD7 RIF1 CSE1L TIAL1 LMO7 RBM7 AATF HAL CTNNB1	8.25e-06	1371	207	23	36244648
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	MAP1B SPTBN1 DNAJC6 ADGRL3 TOM1L2 GRIN1 DYRK1B MACF1 RIMS1 CTNNB1 SRRM2	8.38e-06	347	207	11	17114649
Pubmed	Interaction network of human early embryonic transcription factors.	ZNF148 MECOM KMT2A UHRF2 HYOU1 ARID4A ZSCAN4 CHD7 NCOA1 ZFHX3 CTNNB1	9.33e-06	351	207	11	38297188
Pubmed	KIR haplotype content at the allele level in 77 Northern Irish families.	KIR2DS2 KIR2DS4 KIR3DL1	1.14e-05	8	207	3	17200871
Pubmed	NullHap--a versatile application to estimate haplotype frequencies from unphased genotypes in the presence of null alleles.	KIR2DS2 KIR2DS1 KIR2DS4	1.14e-05	8	207	3	18681957
Pubmed	Overlapping Activities of Two Neuronal Splicing Factors Switch the GABA Effect from Excitatory to Inhibitory by Regulating REST.	MYO7A CLASP2 ADGRL2 GRIN1 OGDH MACF1 RIMS1	1.23e-05	128	207	7	30995482
Pubmed	NOTCH1 nuclear interactome reveals key regulators of its transcriptional activity and oncogenic function.	RBM10 MDN1 NOTCH1 RIF1 WDR11 FBXW7 NCKAP1L	1.29e-05	129	207	7	23022380
Cytoband	19q13.4	ZIM2 KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	3.05e-05	79	207	5	19q13.4
GeneFamily	CD molecules\|Killer cell immunoglobulin like receptors	KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1	7.91e-06	18	133	4	620
GeneFamily	Dyneins, axonemal	DNAH5 DNAH8 DNAH17	2.45e-04	17	133	3	536
GeneFamily	Adhesion G protein-coupled receptors, subfamily L	ADGRL2 ADGRL3	3.19e-04	4	133	2	918
GeneFamily	EF-hand domain containing\|Plakins	DSP MACF1	1.46e-03	8	133	2	939
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	ZC3H14 ASXL1 ZNF148 MAP1B MECOM TAB2 CLASP2 ACSL4 MDN1 MKLN1 MN1 NUP160 SLC27A3 ARID4A WWP1 ARFGEF1 R3HDM2 STIL RIF1 CSE1L TIA1 NCOA1 MACF1 ZFHX3 TP53BP1	2.03e-08	856	207	25	M4500
Coexpression	GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_DN	SPTBN1 F5 MDN1 KMT2A TCEA3 WWP1 FRMPD1 PELI1 ANKRD55 RIF1 USF3 MACF1	3.82e-08	189	207	12	M3112
ToppCell	COVID-19-Epithelial_cells-Airway_club\|COVID-19 / group, cell type (main and fine annotations)	THSD4 NEXMIF MECOM CAPN13 MAST4 SCNN1G B4GALNT3 DNAH5 DSP MFSD4A LMO7 RIMS1	6.78e-11	185	205	12	cfe6fd73d817e173fe803bc1683c291d9bcb8608
ToppCell	Epithelial-club_cell\|World / Lineage, Cell type, age group and donor	NEXMIF MECOM PLEKHS1 CAPN13 MAST4 SCNN1G B4GALNT3 DNAH5 MFSD4A LMO7 RIMS1	1.69e-09	193	205	11	2bdd09004fa433550958ec42ba4b06271a4aaf7c
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	RAPGEF5 SPTBN1 MECOM MAST4 KMT2A ADGRL2 NOTCH1 ADGRL3 MFSD4A CHD7 MACF1	2.46e-09	200	205	11	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	Fetal_29-31_weeks-Epithelial-club_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MECOM GPR179 CAPN13 MAST4 SCNN1G B4GALNT3 DNAH5 CRTAC1 TBC1D8 RIMS1	9.72e-09	176	205	10	3bbac5c2397535631fce8fa98f6ddb4fe0260351
ToppCell	Adult-Epithelial-club_cell\|Adult / Lineage, Cell type, age group and donor	MECOM PLEKHS1 CAPN13 MAST4 SCNN1G B4GALNT3 DNAH5 DSP MFSD4A RIMS1	2.02e-08	190	205	10	756bff697d30aec56c0ebfca94295f084a15bf37
ToppCell	COVID-19-Epithelial_cells-Airway_goblet\|COVID-19 / group, cell type (main and fine annotations)	NEXMIF MECOM PLEKHS1 CAPN13 SCNN1G B4GALNT3 DNAH5 MFSD4A LMO7 RIMS1	2.02e-08	190	205	10	51ca9ef4df3220487152fcf684147730637c7cc1
ToppCell	COVID-19-Epithelial_cells-Airway_basal\|COVID-19 / group, cell type (main and fine annotations)	MECOM PLEKHS1 CAPN13 MAST4 B4GALNT3 DNAH5 PLXNB1 DSP NTF3	2.24e-07	187	205	9	8407a82e98f56a94ea26562bcb6bbe00a8f41661
ToppCell	LA-13._Vascular_Smooth_Muscle\|LA / Chamber and Cluster_Paper	RAPGEF5 CLASP2 CNN1 ADGRL3 FLNA NTF3 EDIL3 MACF1 RIMS1	2.34e-07	188	205	9	34e1b074a3995aa46ab194eb45115d76d1a5514d
ToppCell	COVID-19-lung-Secretory\|lung / Disease (COVID-19 only), tissue and cell type	MECOM PLEKHS1 CAPN13 SCNN1G B4GALNT3 DNAH5 DSP LMO7 RIMS1	2.45e-07	189	205	9	84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_secretory\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MECOM PLEKHS1 CAPN13 MAST4 SCNN1G DNAH5 DSP LMO7 RIMS1	3.62e-07	198	205	9	af399569c718f5fd971d73a7926768c9311002a3
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	THSD4 TNRC6B MECOM CLASP2 MKLN1 WDPCP KANSL1 NCOA1 FBXW7	3.78e-07	199	205	9	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Alv_Cap\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	CEP85L RAPGEF5 SPTBN1 LUZP1 ADGRL2 SELENOP NPR1 EDIL3 ZP1	3.94e-07	200	205	9	66f7e8ee63c828f17468e79a4b816346b33e8980
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	THSD4 MAP1B CNN1 FLNA NTF3 STIL CHTF18 CDC6	1.10e-06	167	205	8	784776d1fcc098f84d3c2eca58fa56cb9428f434
ToppCell	droplet-Spleen-nan-3m-Myeloid-macrophage\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SIRPA ITGAX ARHGAP22 KIT ADGRL3 HAP1 TBC1D8 RASA4	1.32e-06	171	205	8	5b74df72e36ad04dfb25c72f1ca8efe043f6cda6
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TBC1D1 DNAH8 ADGRL3 FLNA NPR1 NTF3 EDIL3 ZFHX3	1.57e-06	175	205	8	316f2ea930437bf1243b1c0f45e6bd864112c6f2
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TBC1D1 DNAH8 ADGRL3 FLNA NPR1 NTF3 EDIL3 ZFHX3	1.57e-06	175	205	8	a9f08e1e4c2997dcdd3e5d92daac480da19100b8
ToppCell	Control-Fibroblasts-Airway_smooth_muscle\|Control / group, cell type (main and fine annotations)	THSD4 MAP1B CNN1 ADGRL3 FLNA NTF3 EDIL3 ZFHX3	1.94e-06	180	205	8	d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1
ToppCell	Children_(3_yrs)-Epithelial-club_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	NEXMIF MECOM CAPN13 MAST4 SCNN1G DNAH5 CRTAC1 RIMS1	1.94e-06	180	205	8	b509c7d6bdfba672065fb722874bdc68de72ba1c
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TPO EXTL1 ARHGAP22 TBC1D1 B4GALNT3 VWA2 ZFHX3 CDH4	1.94e-06	180	205	8	e8841ef1239f9ee73ac4f4e11faca0742694f368
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_VWA2\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TPO EXTL1 ARHGAP22 TBC1D1 B4GALNT3 VWA2 ZFHX3 CDH4	2.10e-06	182	205	8	72e65a23cd36085bc880087d3cae92395de918a1
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TPO EXTL1 ARHGAP22 TBC1D1 B4GALNT3 VWA2 ZFHX3 CDH4	2.10e-06	182	205	8	05c167158815bf25d509df59ab386e1990712765
ToppCell	Adult-Epithelial-club_cell-D231\|Adult / Lineage, Cell type, age group and donor	MECOM PLEKHS1 CAPN13 MAST4 B4GALNT3 DSP MFSD4A RIMS1	2.57e-06	187	205	8	ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	CEP85L TNRC6B KMT2A ARFGEF1 KANSL1 MACF1 CTNNB1 TP53BP1	2.68e-06	188	205	8	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1B TBC1D1 CNN1 ADGRL3 FLNA NTF3 EDIL3 ZFHX3	2.78e-06	189	205	8	7fbe855bfdb47d35e040b04a80fe4b729a3764e8
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1B TBC1D1 CNN1 ADGRL3 FLNA NTF3 EDIL3 ZFHX3	2.78e-06	189	205	8	06b35abecd29f902cf251fcc1f6ad33db7ab08a2
ToppCell	LA-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	FAM83D CNN1 ADGRL3 FLNA NTF3 EDIL3 MACF1 RIMS1	2.78e-06	189	205	8	6b3e88751b95fc2173f2c3d5061ed632d0c5f01c
ToppCell	IPF-Epithelial-Club\|IPF / Disease state, Lineage and Cell class	MECOM CAPN13 MAST4 SCNN1G B4GALNT3 MFSD4A LMO7 RIMS1	2.78e-06	189	205	8	f3fcef008ef252b29ac6d567fef27f9acf9cd70f
ToppCell	Control-Stromal-SMC\|Stromal / Disease state, Lineage and Cell class	MAP1B RAPGEF5 TBC1D1 CNN1 ADGRL3 FLNA NTF3 EDIL3	3.01e-06	191	205	8	2da83c493e60ad0278848957645277d76737a188
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF148 SPTBN1 TAB2 DSP WWP1 APOB PPARA CTNNB1	3.01e-06	191	205	8	09db184cb90fe282a14474d7217068c58092c6f8
ToppCell	COVID-19-lung-Secretory\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MECOM PLEKHS1 CAPN13 SCNN1G B4GALNT3 DNAH5 LMO7 RIMS1	3.13e-06	192	205	8	59261098ccb52306f837f632ebaea45b90ad30fe
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1B TBC1D1 CNN1 ADGRL3 FLNA NTF3 EDIL3 ZFHX3	3.38e-06	194	205	8	5c3b2b05d1e4f146551fe4c920263d8e6ca34de3
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1B TBC1D1 CNN1 ADGRL3 FLNA NTF3 EDIL3 ZFHX3	3.38e-06	194	205	8	ab9cad697f9209d2889bc02b43b502dfeb2ebfef
ToppCell	Control-Epithelial-ATII\|Epithelial / Disease state, Lineage and Cell class	RAPGEF5 MECOM ACSL4 MAST4 PELI1 NFKBIZ CRTAC1 MACF1	3.38e-06	194	205	8	a01de094f7bfd099bcbb2f94224690a2efb887b4
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RAPGEF5 MECOM MAST4 ADGRL2 KIT ADGRL3 MFSD4A MACF1	3.38e-06	194	205	8	0b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 MAP1B RAPGEF5 CNN1 ADGRL3 FLNA FBLN5 NTF3	3.51e-06	195	205	8	dd281a249854800f737dc22e0f375f66dfb5cf5f
ToppCell	facs-Lung-18m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	THSD4 MAP1B SIRPA ADGRL2 EDIL3 LMO7 RASA4 ZFHX3	3.51e-06	195	205	8	7e0ef92059ff34e368d2324815f49b50e3ca7332
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1B KMT2A ARFGEF1 RIF1 NCOA1 MACF1 SRRM2 UNC80	3.51e-06	195	205	8	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 MAP1B RAPGEF5 CNN1 ADGRL3 FLNA FBLN5 NTF3	3.51e-06	195	205	8	49c99553629cdd83ee56a2e508d5bc8d34b8507b
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1B KMT2A ARFGEF1 RIF1 NCOA1 MACF1 SRRM2 UNC80	3.51e-06	195	205	8	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1B RAPGEF5 CNN1 ADGRL3 FLNA NTF3 EDIL3 ZFHX3	3.64e-06	196	205	8	b8759e6231e0254797d6c30930407b79440c57bb
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_secretory\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PLEKHS1 B4GALT5 CAPN13 SCNN1G FAM83D DNAH5 PRSS23 RIMS1	3.64e-06	196	205	8	b07db4a53ab9be9aad6fae5e45f9547db829d096
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PLEKHS1 B4GALT5 CAPN13 SCNN1G FAM83D DNAH5 PRSS23 RIMS1	3.64e-06	196	205	8	c366f980cc04abfe1c0c14746c11810c812a42c0
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PLEKHS1 CAPN13 SCNN1G FAM83D TCEA3 PRSS23 LMO7 RIMS1	3.64e-06	196	205	8	c18874f37b90e6afacc562b2082b67ea8a7cb4a4
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 MAP1B CNN1 ADGRL3 FLNA FBLN5 NTF3 PRSS23	3.64e-06	196	205	8	fa445f4240c521cf04eb2e2f79a5c55fda31209a
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 MAP1B CNN1 ADGRL3 FLNA FBLN5 NTF3 PRSS23	3.64e-06	196	205	8	802f61e78a9a1030a86c4a980c398a73cd4d1574
ToppCell	COPD-Epithelial-Club\|Epithelial / Disease state, Lineage and Cell class	MECOM B4GALT5 MAST4 MFSD4A PELI1 LMO7 RIMS1 CTNNB1	3.64e-06	196	205	8	af96fb94886e9395f3e2cd0a293af29229d017fe
ToppCell	Fetal_29-31_weeks-Epithelial-club_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	NEXMIF MECOM CAPN13 MAST4 SCNN1G DNAH5 CRTAC1 LMO7	3.93e-06	198	205	8	5fc25b008a4d8d6bec83923a16f64dd9e1ff1f2d
ToppCell	NS-critical-LOC-Epithelial-Secretory_LYPD2\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CAPN13 MMP10 DSP MFSD4A PRSS23 EDIL3 LMO7 RIMS1	3.93e-06	198	205	8	4a481e1edb80b950c823ed926842cd5132cfb27f
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_basal-Suprabasal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PLEKHS1 CAPN13 SERPINI2 SCNN1G NOTCH1 DSP PRSS23 RIMS1	3.93e-06	198	205	8	19d8ff3a4f911b13ecc34844202925475ad4d2ab
ToppCell	(09)_Interm._secr.>cil.-(2)_GFP_FOXI1\|(09)_Interm._secr.>cil. / shred by cell type by condition	TNRC6B PARP9 KIT DNAH5 WWP1 NFKBIZ LMO7 RLIM	4.07e-06	199	205	8	fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell	control-HLA-DR+_CD83+_Monocyte\|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SIRPA ITGAX NFKBIZ MIDN NCOA1 ZFHX3 TBR1 FBXW7	4.07e-06	199	205	8	f1b370d2869ad29c9d8ff41fdcc486fffa781ee2
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	MAP1B TNRC6B PARP9 KIT WWP1 ARFGEF1 LMO7 RLIM	4.07e-06	199	205	8	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	Tracheal-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Goblet\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	PLEKHS1 ABCA7 B4GALT5 CAPN13 FAM83D TCEA3 LMO7 RIMS1	4.07e-06	199	205	8	e03bdc7cb825e287f41b834ec6061d23c1c03b04
ToppCell	ILEUM-inflamed-(8)_Fibroblast-(8)_Fibroblasts\|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	SPTBN1 TNRC6B ADGRL2 ADGRL3 SELENOP FBLN5 ARID4A EDIL3	4.07e-06	199	205	8	615f20bf136dfef53b072667cf0e4df6a1017e05
ToppCell	LPS_only-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_only / Treatment groups by lineage, cell group, cell type	CEP85L RAPGEF5 SPTBN1 LUZP1 MAST4 KMT2A ADGRL2 MACF1	4.23e-06	200	205	8	edb64556b3fefe3144f73b6efe23b9ffd34091d2
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated\|COVID-19_Mild / Disease, condition lineage and cell class	SPTBN1 TRANK1 MDN1 MAST4 PARP9 IL24 FBLN5 ANKRD55	4.23e-06	200	205	8	d9e8a0d047d4403fb7265fde7448e23a7780785c
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Alv_Cap\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	CEP85L RAPGEF5 SPTBN1 LUZP1 ADGRL2 SELENOP NPR1 EDIL3	4.23e-06	200	205	8	b7533c571eeea0cb3678e1a57d3dc036fa8d0f49
ToppCell	Control_saline-Endothelial-Endothelial-Alv_Cap\|Control_saline / Treatment groups by lineage, cell group, cell type	CEP85L RAPGEF5 SPTBN1 LUZP1 ADGRL2 SELENOP NPR1 EDIL3	4.23e-06	200	205	8	abf4ba5fcb54cdeada0da1a8b956a30aa47679e4
ToppCell	LPS_only-Endothelial-Endothelial\|LPS_only / Treatment groups by lineage, cell group, cell type	RAPGEF5 SPTBN1 LUZP1 MAST4 ADGRL2 NPR1 MFSD4A MACF1	4.23e-06	200	205	8	4bb609a284d4e6066f17470a1736076aa4a1f84c
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MAP1B TBC1D1 FAM83D CNN1 ADGRL3 FLNA NTF3 EDIL3	4.23e-06	200	205	8	a66449b22b39dd6987fc2c3ed160d24564234ced
ToppCell	LPS_only-Endothelial\|LPS_only / Treatment groups by lineage, cell group, cell type	RAPGEF5 SPTBN1 LUZP1 MAST4 ADGRL2 NPR1 MFSD4A MACF1	4.23e-06	200	205	8	81e76508c9050d533853d5fd2f3097b27613d836
ToppCell	Bronchus_Control_(B.)-Epithelial-TX\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	PLEKHS1 CAPN13 MAST4 MMP10 DNAH5 DSP PRSS23 LMO7	4.23e-06	200	205	8	f5bc7d30aa03dd0f95eb64255bd1a2543be8d327
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	RAPGEF5 SPTBN1 MECOM MAST4 ADGRL3 NPR1 MFSD4A MACF1	4.23e-06	200	205	8	a2b9d1cd291d17abddc3ee2e242121412c864b8b
ToppCell	COVID-19-Epithelial_cells-Airway_mucous\|COVID-19 / group, cell type (main and fine annotations)	MECOM PLEKHS1 CAPN13 SERPINI2 DNAH5 DSP LMO7	6.52e-06	151	205	7	8216462e723fec2797387929dde095370947e10a
ToppCell	Fetal_29-31_weeks-Epithelial-club_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MECOM MAST4 DNAH5 ZSCAN4 CRTAC1 TBC1D8 RIMS1	1.03e-05	162	205	7	5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81
ToppCell	Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MAP1B DNAJC6 TBC1D1 CNN1 ADGRL3 FLNA EDIL3	1.16e-05	165	205	7	8a82e20c9b1156bb4bbc16f7785abb04458d671b
ToppCell	10x5'-bone_marrow-Hematopoietic_progenitors-Progenitor_MEMP\|bone_marrow / Manually curated celltypes from each tissue	ZIM2 MECOM ARHGAP22 KIT VWA2 NTF3 PDZD2	1.21e-05	166	205	7	9788486582cc2c5f28b9ea015e235732f9fefb1e
ToppCell	tumor_Lymph_Node_/_Brain-T/NK_cells-CD8+/CD4+_Mixed_Th\|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass	ZNF410 TAB2 TRAPPC13 TRANK1 ANKRD55 TIAL1 NCKAP1L	1.26e-05	167	205	7	c0c944eae0514dc8e00d0c2892a0792e157695ec
ToppCell	droplet-Spleen-SPLEEN-1m-Myeloid-macrophage\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SIRPA ITGAX ARHGAP22 KIT HAP1 TBC1D8 RASA4	1.41e-05	170	205	7	670027daec5a10dfa12246f1497b58db21d32a22
ToppCell	cellseq2-Epithelial-Epithelial_Glandular-Goblet\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CAPN13 SCNN1G FAM83D MMP10 PRSS23 LMO7 RIMS1	1.47e-05	171	205	7	fe27bf581c75ef33c2848878e51ed16b275a4c8e
ToppCell	cellseq2-Epithelial-Epithelial_Glandular-Goblet-Goblet\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CAPN13 SCNN1G FAM83D MMP10 PRSS23 LMO7 RIMS1	1.47e-05	171	205	7	25c1979e972c959e1ce4c57804f976f53a247ad7
ToppCell	droplet-Spleen-nan-21m-Myeloid-macrophage\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SIRPA ITGAX ARHGAP22 SCNN1G KIT TBC1D8 RASA4	1.52e-05	172	205	7	4fe5b91e4871bc6c5be57eb5b8bb04815b2fb80d
ToppCell	E12.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	TATDN2 KIT NPR1 POLR1A FAM171B ANKRD55 PLEKHM3	1.52e-05	172	205	7	3b9be685fcd1634498a603b692f5ac6ddd0de176
ToppCell	Children_(3_yrs)-Epithelial-lung_goblet_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PLEKHS1 CAPN13 SCNN1G FAM83D DNAH5 NTF3 RIMS1	1.58e-05	173	205	7	464267a2ff3f5c387b6c9c6fa4dab135a221f448
ToppCell	Control-CD4+_T_activated\|Control / Disease condition and Cell class	NEXMIF EXTL1 PARP9 DNAH5 SEC14L4 CDH4	1.63e-05	116	205	6	e3d1a90a229f5697b2b715574bb96790a435f73b
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ZNF391 FAM83D MMP10 MFSD4A PRSS23 NCOA1 RIMS1	1.64e-05	174	205	7	42f2ba54b4ea4c62482582b0ccdadffae0a5eb4a
ToppCell	P03-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ARHGAP22 SCNN1G FBLN5 DSP WWP1 LMO7 MACF1	1.77e-05	176	205	7	f3a54038cde58326f1caed96ecca33c141bcc8b3
ToppCell	nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PLEKHS1 CAPN13 SCNN1G PLEKHA5 MMP10 NTF3 PRSS23	1.83e-05	177	205	7	cbad1a23851151dbef01ea2af960e6f0944f838b
ToppCell	nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal-Basal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PLEKHS1 CAPN13 SCNN1G PLEKHA5 MMP10 NTF3 PRSS23	1.83e-05	177	205	7	ce86dfaeb74d995a19aea62f0fb15c4c0bb854b0
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PLEKHS1 B4GALNT3 DSP MFSD4A LMO7 MACF1 RIMS1	1.97e-05	179	205	7	6e965e424eebef50f0202cff75f458be395cfca1
ToppCell	Adult-Epithelial-lung_goblet_cell\|Adult / Lineage, Cell type, age group and donor	PLEKHS1 CAPN13 FAM83D DSP MFSD4A PRSS23 RIMS1	1.97e-05	179	205	7	1fc1f252ca943a2f649d1e627f56acbf15f8e058
ToppCell	COVID-19-kidney-vSMC/Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	TBC1D1 CNN1 ADGRL3 IL24 NTF3 EDIL3 ZFHX3	1.97e-05	179	205	7	111b1084f73306bdeffaaf240e7dbb4f5bf33de1
ToppCell	Transplant_Alveoli_and_parenchyma-Epithelial-Type_1_alveolar\|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X	SPTBN1 ABCA7 SCNN1G B4GALNT3 MFSD4A LMO7 CDH4	1.97e-05	179	205	7	d5763912a4ce7188535675e338799b856edb9dda
ToppCell	droplet-Liver-LIVER_NPC-30m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1B MECOM MAST4 DNAH8 SLC27A3 NPR1 RALGAPB	1.97e-05	179	205	7	025d414ec88d5680d99c8173e70ee3bb0b694f74
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-myocytic-myofibroblast\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MAP1B NEXMIF CNN1 ADGRL3 FLNA ZP1 DMC1	2.12e-05	181	205	7	fc51468c74534b60b4e786bd512d0f1c5dc05de7
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MAP1B MECOM ARMCX4 LUZP1 NOTCH1 NPR1 FBLN5	2.12e-05	181	205	7	4d7793026373cbcf04b15c77f95f1025d07d4c00
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	THSD4 RAPGEF5 MECOM B4GALNT3 NFKBIZ LMO7 HAL	2.12e-05	181	205	7	576da14ab3107f89e1f44a4a439d1bef5bb42370
ToppCell	Children_(3_yrs)-Epithelial-club_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MECOM PLEKHS1 CAPN13 SCNN1G DNAH5 MFSD4A LMO7	2.19e-05	182	205	7	215c303df42f13597b2c7a95cb157c6bc7aca9a1
ToppCell	Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D175\|Adult / Lineage, Cell type, age group and donor	THSD4 CEP85L RAPGEF5 SPTBN1 C16orf78 ADGRL2 ADGRL3	2.19e-05	182	205	7	8b4a07ebd7a133a33ef333cfa29d12c4f3d4d9ac
ToppCell	Children_(3_yrs)-Epithelial-lung_goblet_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PLEKHS1 CAPN13 SCNN1G B4GALNT3 DNAH5 NTF3 RIMS1	2.19e-05	182	205	7	3f1a666fe27dd7529c114539ed5f6b8ca585c875
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MAP1B MECOM ARMCX4 LUZP1 NOTCH1 NPR1 FBLN5	2.27e-05	183	205	7	3427f3cbe6ea81709750e7dd3ff378f03ae65eab
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	THSD4 MAP1B CNN1 ADGRL3 FLNA EDIL3 ZP1	2.27e-05	183	205	7	af8d86f15a549064530d94bd47081daf59d58ecd
ToppCell	Substantia_nigra-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6_(Thalamus,_glutamatergic)-\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	PRSS45P B4GALNT3 SEC14L4 APOB STIL	2.33e-05	74	205	5	ef4c9eafc794c7d50aef28b37d21b52d3c511499
ToppCell	Substantia_nigra-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6_(Thalamus,_glutamatergic)\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	PRSS45P B4GALNT3 SEC14L4 APOB STIL	2.33e-05	74	205	5	6ecbdf4186039a031410e09ecd5afa66b6d5e2dc
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1B RAPGEF5 ADGRL3 FLNA NTF3 EDIL3 ZFHX3	2.43e-05	185	205	7	51dfe6ac7df8b330343b37e3bee71e5c65267189
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1B RAPGEF5 ADGRL3 FLNA NTF3 EDIL3 ZFHX3	2.43e-05	185	205	7	a8c02cec3c414f3a0da9f2d6d28ce563b0030705
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	THSD4 MAP1B CNN1 TCEA3 FLNA NTF3 RIMS1	2.52e-05	186	205	7	6add08d4ca019ff2864acdd5ec2c66a59a574591
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	RAPGEF5 MECOM ACSL4 MAST4 B4GALNT3 NFKBIZ HAL	2.52e-05	186	205	7	acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ARMCX4 MMP10 MFSD4A CHD7 PRSS23 NCOA1 RIMS1	2.61e-05	187	205	7	f5a202d5f8eb57b57d80815ce98774e04c387383
ToppCell	COVID-19-Epithelial_cells\|COVID-19 / group, cell type (main and fine annotations)	THSD4 MECOM MAST4 B4GALNT3 DNAH5 LMO7 PDZD2	2.70e-05	188	205	7	c9cdee6f8d42ee69f5fb335f25084603c511bd29
Disease	Neurodevelopmental Disorders	NEXMIF TNRC6B KMT2A PLXNB1 RIMS1 CTNNB1 TBR1	2.90e-06	93	195	7	C1535926
Disease	Colorectal Carcinoma	MAP1B RBM10 F5 ACSL4 SCNN1G UHRF2 VWA2 DNAH8 SELENOP ARFGEF1 NTNG1 APOB CSE1L LMO7 CTNNB1 SLC29A1 FBXW7	4.75e-06	702	195	17	C0009402
Disease	Severe dermatitis, multiple allergies, metabolic wasting syndrome	DSG1 DSP	4.35e-05	2	195	2	C3809719
Disease	Malignant neoplasm of breast	CTU2 CEP85L MECOM CDH20 MMP10 SMOX KIT NOTCH1 PLXNB1 IL24 FLNA C1orf87 FRMPD1 RIF1 NCOA1 MACF1 CTNNB1 TP53BP1 FBXW7	1.00e-04	1074	195	19	C0006142
Disease	testosterone measurement	CYP7A1 WDR81 MECOM TYK2 ADGRL2 NUP160 MGRN1 POLR1A DET1 POLR2A NTNG1 CRTAC1 R3HDM2 CHD7 PPARA TBC1D8 WDR11 NCOA1 MACF1 ZFHX3 PLEKHM3	1.16e-04	1275	195	21	EFO_0004908
Disease	Striate palmoplantar keratoderma	DSG1 DSP	1.30e-04	3	195	2	C4707237
Disease	Systemic mastocytosis with associated clonal, hematologic non-mast-cell lineage disease	ASXL1 KIT	2.58e-04	4	195	2	C1301365
Disease	Adult Acute Lymphocytic Leukemia	NOTCH1 FBXW7	2.58e-04	4	195	2	C0751606
Disease	ovarian neoplasm	MECOM RAD51D KANSL1 DYRK1B CTNNB1 TP53BP1	2.75e-04	134	195	6	C0919267
Disease	coagulation factor V measurement	F5 MAST4 SELENOP	2.98e-04	20	195	3	EFO_0008087
Disease	Malignant neoplasm of ovary	MECOM RAD51D KANSL1 DYRK1B CTNNB1 TP53BP1	3.09e-04	137	195	6	C1140680
Disease	glycine measurement	GVINP1 UHRF2 R3HDM2 PLEKHM3 UNC80 TP53BP1	3.09e-04	137	195	6	EFO_0009767
Disease	serum urea measurement	MECOM CDH20 MYL10 ADGRL2 SELENOP R3HDM2 PRSS23	3.32e-04	195	195	7	EFO_0009795
Disease	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	TYK2 NOTCH1 STIL FBXW7	4.20e-04	53	195	4	C1961099
Disease	cadherin-7 measurement	F5 SELENOP	4.29e-04	5	195	2	EFO_0801438
Disease	C-C motif chemokine 27 measurement	GALT PPARA	4.29e-04	5	195	2	EFO_0020198
Disease	lactosyl-N-palmitoyl-sphingosine (d18:1/16:0) measurement	ABCA7 CHD7	4.29e-04	5	195	2	EFO_0800429
Disease	Acute myelomonocytic leukemia	KMT2A KIT	4.29e-04	5	195	2	C0023479
Disease	rheumatoid arthritis, ACPA-negative rheumatoid arthritis	TYK2 ANKRD55	4.29e-04	5	195	2	EFO_0000685, EFO_0009460
Disease	photoreceptor cell layer thickness measurement	ZNF410 MAP1B ARHGAP22 MN1 CHD7 MEAK7	4.67e-04	148	195	6	EFO_0803370
Disease	Neoplasm of the genitourinary tract	KIT ZFHX3 CTNNB1	5.19e-04	24	195	3	cv:C0042065
Disease	autism spectrum disorder (implicated_via_orthology)	NEXMIF CHD7 GRIN1 RIMS1 CTNNB1 TBR1	5.38e-04	152	195	6	DOID:0060041 (implicated_via_orthology)
Disease	periventricular nodular heterotopia (is_implicated_in)	MAP1B FLNA	6.40e-04	6	195	2	DOID:0050454 (is_implicated_in)
Disease	torsin-1A-interacting protein 1 measurement	F5 SELENOP	6.40e-04	6	195	2	EFO_0802137
Disease	solute carrier family 22 member 16 measurement	F5 SELENOP	6.40e-04	6	195	2	EFO_0802079
Disease	Antiglaucoma preparations and miotics use measurement	MECOM KMT2A NUP160	6.61e-04	26	195	3	EFO_0009944
Disease	Ciliopathies	MYO7A SCNN1G DNAH5 DNAH8 WDPCP	8.36e-04	110	195	5	C4277690
Disease	Prostatic Neoplasms	ACSL4 KMT2A IL24 SELENOP FBLN5 ARID4A CHD7 PPARA RLIM NCOA1 ZFHX3 CTNNB1	8.67e-04	616	195	12	C0033578
Disease	Malignant neoplasm of prostate	ACSL4 KMT2A IL24 SELENOP FBLN5 ARID4A CHD7 PPARA RLIM NCOA1 ZFHX3 CTNNB1	8.67e-04	616	195	12	C0376358
Disease	triglyceride measurement, intermediate density lipoprotein measurement	CYP7A1 CRTAC1 R3HDM2 APOB TP53BP1	8.71e-04	111	195	5	EFO_0004530, EFO_0008595
Disease	Acute lymphocytic leukemia	NOTCH1 FBXW7	8.93e-04	7	195	2	C0023449
Disease	Periventricular Nodular Heterotopia	MAP1B FLNA	8.93e-04	7	195	2	C1868720
Disease	mean corpuscular hemoglobin concentration	TNRC6B MECOM SIRPA ABCA7 PARP9 SMOX MN1 POLR1A ARID4A POLR2A BEND3 MEAK7 RIF1 CHTF18 MACF1 SLC29A1 WIPI2	1.12e-03	1105	195	17	EFO_0004528
Disease	myelofibrosis (is_implicated_in)	ASXL1 KMT2A	1.19e-03	8	195	2	DOID:4971 (is_implicated_in)
Disease	cocaine use disorder, social environment measurement	ADGRL2 TRAK2	1.19e-03	8	195	2	EFO_0010445, EFO_0010552
Disease	Lymphoid leukemia	MECOM KMT2A	1.19e-03	8	195	2	C0023448
Disease	glycoprotein measurement	R3HDM2 APOB ZFHX3 CDH4 TP53BP1	1.19e-03	119	195	5	EFO_0004555
Disease	lung carcinoma	NAF1 MKLN1 ADGRL2 CRTAC1 OGDH RIF1 SLF2 NCOA1 RIMS1 TP53BP1	1.46e-03	482	195	10	EFO_0001071
Disease	lactosyl-N-nervonoyl-sphingosine (d18:1/24:1) measurement	ABCA7 CHD7	1.52e-03	9	195	2	EFO_0800517
Disease	cortical surface area measurement	THSD4 RAPGEF5 SPTBN1 TNRC6B MECOM LUZP1 TBC1D16 MAST4 ACAD11 ADGRL2 KIT BEND3 CRTAC1 CHD7 KANSL1 MACF1 ZFHX3 PLEKHM3 PDZD2	1.56e-03	1345	195	19	EFO_0010736
Disease	Malignant Neoplasms	PLEKHS1 KIT NOTCH1 PPARA CTNNB1	1.64e-03	128	195	5	C0006826
Disease	Manic	TRANK1 DNAH8 NTNG1 RIMS1	1.80e-03	78	195	4	C0338831
Disease	Lung diseases	SCNN1G KIT DNAH5 FBLN5	1.80e-03	78	195	4	C0024115
Disease	Paranoia	TYK2 DNAH8	2.30e-03	11	195	2	C1456784
Disease	Hand-foot syndrome, response to fluoropyrimidines	WDR11 CDH4	2.30e-03	11	195	2	EFO_0010825, EFO_1001893
Disease	insulin sensitivity measurement, response to polyunsaturated fatty acid supplementation	TNRC6B ADGRL2	2.30e-03	11	195	2	EFO_0004471, EFO_0009131
Disease	follistatin measurement	R3HDM2 TP53BP1	2.30e-03	11	195	2	EFO_0010614
Disease	Mammary Carcinoma, Human	CTU2 MECOM KIT NOTCH1 IL24 FLNA NCOA1 CTNNB1 TP53BP1 FBXW7	2.71e-03	525	195	10	C4704874
Disease	Mammary Neoplasms, Human	CTU2 MECOM KIT NOTCH1 IL24 FLNA NCOA1 CTNNB1 TP53BP1 FBXW7	2.71e-03	525	195	10	C1257931
Disease	level of Ceramide (d42:2) in blood serum	CYP7A1 APOB	2.75e-03	12	195	2	OBA_2045186
Disease	acute myeloid leukemia (implicated_via_orthology)	KMT2A ARID4A	2.75e-03	12	195	2	DOID:9119 (implicated_via_orthology)
Disease	Mammary Neoplasms	CTU2 MECOM KIT NOTCH1 IL24 FLNA NCOA1 CTNNB1 TP53BP1 FBXW7	2.79e-03	527	195	10	C1458155
Disease	electrocardiography	CEP85L SPTBN1 TAB2 LUZP1 AMZ2 TRANK1 MAST4 MKLN1 TCEA3 WDPCP	2.90e-03	530	195	10	EFO_0004327
Disease	non-high density lipoprotein cholesterol measurement	CYP7A1 WDR81 TYK2 B4GALNT3 R3HDM2 APOB CHD7 PPARA WDPCP TBC1D8 CSE1L TRAK2	2.93e-03	713	195	12	EFO_0005689
Disease	severe acute respiratory syndrome, COVID-19	THSD4 MYO7A B4GALT5 MKLN1 KIR2DS4 ADGRL3 EDIL3 ZFHX3 PDZD2	3.05e-03	447	195	9	EFO_0000694, MONDO_0100096
Disease	obesity (implicated_via_orthology)	TYK2 NOTCH1 PLXNB1 NCOA1 ZFHX3 CTNNB1	3.16e-03	215	195	6	DOID:9970 (implicated_via_orthology)
Disease	Breast Carcinoma	CTU2 MECOM KIT NOTCH1 IL24 FLNA NCOA1 CTNNB1 TP53BP1 FBXW7	3.23e-03	538	195	10	C0678222
Disease	egg allergy measurement, parental genotype effect measurement	SPATA31C2 ANKRD55	3.23e-03	13	195	2	EFO_0005939, EFO_0007018
Disease	T-cell surface glycoprotein CD3 epsilon chain measurement	F5 SELENOP	3.23e-03	13	195	2	EFO_0802114
Disease	advanced glycosylation end product-specific receptor, soluble measurement	B4GALNT3 KANSL1	3.23e-03	13	195	2	EFO_0020131
Disease	late-onset Alzheimers disease	THSD4 RAPGEF5 MECOM ABCA7 ADGRL2 SELENOP FAM171A2	3.41e-03	292	195	7	EFO_1001870
Disease	Colonic Neoplasms	MECOM F5 NOTCH1 CTNNB1 TP53BP1	3.46e-03	152	195	5	C0009375
Disease	Acute Promyelocytic Leukemia	ASXL1 ITGAX KIT	3.50e-03	46	195	3	C0023487
Disease	very low density lipoprotein cholesterol measurement, lipid measurement	CYP7A1 TBC1D1 CRTAC1 R3HDM2 APOB TP53BP1	3.53e-03	220	195	6	EFO_0004529, EFO_0008317
Disease	free androgen index	CYP7A1 TYK2 NUP160 R3HDM2 CHD7 PPARA MIDN WDR11	3.57e-03	374	195	8	EFO_0007005
Disease	glaucoma	RAPGEF5 MECOM KMT2A PRSS23 LMO7	3.66e-03	154	195	5	MONDO_0005041
Disease	response to methotrexate, aspartate aminotransferase measurement	THSD4 SELENOP	3.75e-03	14	195	2	EFO_0004736, GO_0031427
Disease	tetralogy of Fallot (implicated_via_orthology)	DNAH5 NTF3	3.75e-03	14	195	2	DOID:6419 (implicated_via_orthology)
Disease	alcohol consumption measurement	SPTBN1 B4GALT5 MAST4 ADGRL2 KIT DNAH5 NUP160 TOM1L2 ARID4A CRTAC1 WDPCP DMC1 TRBV24-1 KANSL1 AATF ZFHX3 CDH4	3.77e-03	1242	195	17	EFO_0007878
Disease	Adenocarcinoma of large intestine	TYK2 KIT CTNNB1 FBXW7	3.83e-03	96	195	4	C1319315
Disease	triglyceride measurement, very low density lipoprotein cholesterol measurement	CYP7A1 CRTAC1 R3HDM2 APOB MACF1 TP53BP1	3.86e-03	224	195	6	EFO_0004530, EFO_0008317
Disease	hearing impairment	MYO7A MN1 NTF3 CHD7	4.12e-03	98	195	4	C1384666
Disease	Malignant tumor of colon	MECOM F5 NOTCH1 CTNNB1 TP53BP1	4.19e-03	159	195	5	C0007102
Disease	very low density lipoprotein cholesterol measurement, phospholipid measurement	CYP7A1 TBC1D1 CRTAC1 R3HDM2 APOB TP53BP1	4.29e-03	229	195	6	EFO_0004639, EFO_0008317
Disease	hepatoblastoma (is_marker_for)	ZFHX3 CTNNB1	4.31e-03	15	195	2	DOID:687 (is_marker_for)
Disease	Hypertriglyceridemia	APOB PPARA	4.31e-03	15	195	2	C0020557
Disease	amenorrhea, response to antineoplastic agent	APOB RIMS1	4.31e-03	15	195	2	EFO_0010269, GO_0097327
Disease	diet measurement	C16orf78 TNRC6B TRANK1 SERPINI2 CDH20 PRPF40B ADGRL2 DNAH5 APOB APLF WDPCP SCYL2 ZFHX3 RIMS1 CDH4	4.31e-03	1049	195	15	EFO_0008111
Disease	Adenoid Cystic Carcinoma	ZIM2 NOTCH1 KANSL1 FBXW7	4.43e-03	100	195	4	C0010606
Disease	cholesteryl esters to total lipids in IDL percentage	APOB MACF1 TP53BP1	4.43e-03	50	195	3	EFO_0022247
Disease	reticulocyte measurement	TNRC6B SIRPA SGO1 ITGAX CDH20 SMOX SEC14L4 FLNA BEND3 ANKRD55 TBC1D8 KANSL1 DNAH17 WIPI2 PDZD2	4.47e-03	1053	195	15	EFO_0010700
Disease	platelet crit	CTU2 MECOM SIRPA ITGAX TYK2 PWWP2A MAST4 KIT MN1 NUP160 ACBD5 APOB MEAK7 KANSL1	4.53e-03	952	195	14	EFO_0007985
Disease	dyslexia	CEP85L MOV10L1 ADGRL2 C1orf87 CRTAC1	4.53e-03	162	195	5	EFO_0005424
Disease	Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse	NOTCH1 CTNNB1	4.91e-03	16	195	2	C0334634
Disease	thyroid volume	DNAH5 AATF	4.91e-03	16	195	2	EFO_0004865
Disease	Childhood Acute Lymphoblastic Leukemia	KMT2A NOTCH1 FBXW7	4.95e-03	52	195	3	C0023452
Disease	triglyceride measurement, low density lipoprotein cholesterol measurement	CYP7A1 CRTAC1 R3HDM2 APOB TP53BP1	5.02e-03	166	195	5	EFO_0004530, EFO_0004611
Disease	neuroimaging measurement	THSD4 MAP1B SPTBN1 TNRC6B LUZP1 TYK2 ARHGAP22 MAST4 ACAD11 BEND3 CHD7 MEAK7 KANSL1 RLIM MACF1	5.12e-03	1069	195	15	EFO_0004346
Disease	QRS-T angle	CEP85L SPTBN1 KMT2A KANSL1	5.44e-03	106	195	4	EFO_0020097
Disease	Acute Cerebrovascular Accidents	F5 SMOX ZFHX3	5.50e-03	54	195	3	C0751956
Disease	cyclic adenosine monophosphate measurement	MAST4 OFCC1	5.54e-03	17	195	2	EFO_0010473
Disease	Lipidemias	APOB PPARA	5.54e-03	17	195	2	C1706412
Disease	Hyperlipidemia	APOB PPARA	5.54e-03	17	195	2	C0020473
Disease	upper aerodigestive tract neoplasm	THSD4 PLEKHS1 TBC1D1 ADGRL2 MEAK7 ZFHX3	6.05e-03	246	195	6	EFO_0004284
Disease	cholesteryl ester measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement	CYP7A1 CRTAC1 R3HDM2 APOB	6.19e-03	110	195	4	EFO_0008317, EFO_0008596, EFO_0010351
Disease	RS-10-hydroxywarfarin to RS-warfarin ratio measurement	CEP85L SELENOP GCFC2 WIPI2	6.19e-03	110	195	4	EFO_0803335
Disease	chylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement	CYP7A1 CRTAC1 R3HDM2 APOB	6.19e-03	110	195	4	EFO_0004574, EFO_0008317, EFO_0008596
Disease	alcoholic hepatitis (biomarker_via_orthology)	CYP7A1 PPARA	6.20e-03	18	195	2	DOID:12351 (biomarker_via_orthology)
Disease	Feeding difficulties	MN1 POLR2A	6.20e-03	18	195	2	C0232466
Disease	Idiopathic hypogonadotropic hypogonadism	CHD7 WDR11	6.20e-03	18	195	2	C0342384

Protein segments in the cluster

Peptide	Gene	Start	Entry
VMSRQPFPEQSQQGE	nan	191	A8MWP4
AEARIQANEFFGMTP	C2orf16	281	Q68DN1
SMQSVEELGSNPENL	ACSL4	246	O60488
RITFPSSQQEAQNRM	CHTF18	716	Q8WVB6
RENEGMPSLIAESNQ	ARID4A	906	P29374
QMTPTNSVSFLGENR	APLF	156	Q8IW19
NEQTLRAAQMFPSES	ANKRD30B	551	Q9BXX2
ETPASNNQNARMLEG	B4GALNT3	441	Q6L9W6
SSQPMENSGFREDIQ	ACBD5	341	Q5T8D3
NAGPIFRTNEMFINA	ARFGEF1	466	Q9Y6D6
TQMSGTDNPEQFEVL	ARFGEF1	681	Q9Y6D6
SSQSIGQVMPNSRQE	CDKL3	466	Q8IVW4
NIFGENPSEMQDILQ	GVINP1	1576	Q7Z2Y8
NNARDTSVMDTLPLN	ADGRL3	1186	Q9HAR2
VLDPMLQEGTFNSQR	C16orf78	156	Q8WTQ4
MPNVAETERSNDSGN	BIVM	1	Q86UB2
RNGISTTPQGDMNSF	BTBD11	721	A6QL63
RDTSAMDTLPLNGNF	ADGRL2	1216	O95490
FNFSVQEPMEGTNVV	CAPN13	371	Q6MZZ7
AGEQRLMNEAFQPAS	AMZ2	31	Q86W34
TMDFSTPSVFDQQRG	ANKRD55	6	Q3KP44
QFNFTMEDGLVNTIP	NPR1	336	P16066
NVAVFVTNQMTADPG	DMC1	261	Q14565
VFPEVQRDSQTGMAN	DET1	271	Q7L5Y6
EQVGTQPFNRAMLFN	B4GALT5	201	O43286
ESPDFQLQAMIQAAG	CHD7	1276	Q9P2D1
PLFSGSNEVDQMNRI	DYRK1B	311	Q9Y463
REDTMGSAQPQVVAN	ARMCX4	901	Q5H9R4
VRAMSQDSNSNAAPG	ASXL1	1246	Q8IXJ9
LGPRIFTFMNDSSNV	ABCA7	331	Q8IZY2
RTVPMINQGSYSENS	ACAD11	266	Q709F0
QMVRGSSDQPEDIGQ	C1orf87	151	Q8N0U7
DDLSNPFGQMSLSRQ	R3HDM2	436	Q9Y2K5
AKSSRQPTGFQEMVD	RAD51D	296	O75771
AVQNVGNMDTPASRA	RASA4	506	O43374
PGADSVSMQAFSRAQ	RBM10	486	P98175
AVQNVGNMDTPASRA	RASA4B	506	C9J798
QLPGQEAFMRAQTTT	ITGAX	1081	P20702
AVMDQEPAGNRTVNS	KIR2DS2	276	P43631
LGQETTPSFNAMVVN	PARP9	301	Q8IXQ6
GSQSPRNVEERMNGS	MECOM	1036	Q03112
AQREMEDSQPSGQVA	BEND3	341	Q5T5X7
DENSQSMEQGFPRLI	MMP10	411	P09238
GSSQFEFDPNARMVT	MMP10	451	P09238
QDGNTTRQEMSPAGV	RSPH10B	31	P0C881
QDGNTTRQEMSPAGV	RSPH10B2	31	B2RC85
NMNIAIEEAPESFGQ	DDI1	226	Q8WTU0
DTQRRTSMGGTQQQF	CTNNB1	546	P35222
AVMDQEPAGNRTVNS	KIR2DS4	276	P43632
NRQTESQIMGELPFT	nan	746	O00370
EEAGTNPALLSQNSM	MDN1	3606	Q9NU22
SADANIQDNMGRTPL	NOTCH1	1951	P46531
PFQVRGSQQMIDQAS	NFKBIZ	271	Q9BYH8
DQRESENIANPMQTS	NFKBIZ	346	Q9BYH8
QESPEQSLAMDFSRQ	MAP1B	1651	P46821
QMSESSLVNNRGISP	MOV10L1	361	Q9BXT6
VSALTAQQMRFEPDN	LYSMD3	186	Q7Z3D4
FPMINTTVFVNDGEN	KIT	316	P10721
SVPTQDRSIGMENSE	MFSD4A	496	Q8N468
QDTERPQTLLQMSGS	GPR179	1666	Q6PRD1
RILNSNPVMEAFGNA	MYO19	171	Q96H55
PGMTRDDLFNTNATI	MDH2	106	P40926
GTFMPSIDVTNESRN	ERVMER34-1	156	Q9H9K5
ENMDLNFLGSRPVQF	MGRN1	56	O60291
PSEMGELEATRQNQS	ARNTL2	566	Q8WYA1
AVMDQEPAGNRTANS	KIR3DL1	371	P43629
DSLPEFTVQMGNLRF	PLXNB1	1456	O43157
SENQSEAGTLLPQMA	PDZD2	2401	O15018
ANPRQQMNGLTSFLD	TPO	311	P07202
NMTSQRPVSSTGINF	NCOA5	521	Q9HCD5
FNPQGFLTAMRQEVT	DNAH8	4351	Q96JB1
TTQTDMDENILFPRG	FAM83D	441	Q9H4H8
MDENILFPRGTQSTE	FAM83D	446	Q9H4H8
AMQAFVSLPREGEQN	NCKAP1L	811	P55160
ENLRTMNTSGQTALP	KANSL1	136	Q7Z3B3
DQFSDMRISINQTPG	LMO7	1036	Q8WWI1
PASASQAFTIMDQNR	MYL10	86	Q9BUA6
GPSENVSQEQFTASM	MEAK7	81	Q6P9B6
AKEQFMVQRGTTPDN	PLEKHM3	91	Q6ZWE6
IQGNNMDQRSLPEDS	NTF3	16	P20783
QEPSDSPMFIINRNT	DSG1	201	Q02413
SRMLASGNQPDQDIT	MACF1	4241	Q9UPN3
MVRQPSRESTDGSIN	RIMS1	1481	Q86UR5
TQQEMRAFPAFLGTE	FAM171A2	181	A8MVW0
REATEGTGNPAFNMS	OFCC1	31	Q8IZS5
VVNNQIGFTTDPRMA	OGDH	441	Q02218
SNQGELQIFDMALSP	WDPCP	396	O95876
NEDMVFRGNIDNNTP	EDIL3	266	O43854
IPDFARSGVQMNTNF	APOB	891	P04114
GPVQQALQSAEMSLD	HYOU1	361	Q9Y4L1
ELLDSMAQQTPVGNA	HIKESHI	116	Q53FT3
ELNSATDNPMVFANR	HAL	421	P42357
TDNPMVFANRGETVS	HAL	426	P42357
MAQPESSADFGIAQQ	C6orf52	1	Q5T4I8
NQGLPSDRMSTENAT	DNAH17	3416	Q9UFH2
FENSAMRTSIPQLEN	GCFC2	711	P16383
DGENNMRQSPQTVFS	GJA9	396	P57773
GMVRANLPQSFQVDT	FLNA	1461	P21333
EMRFLNLGPFQDTTT	CDH20	361	Q9HBT6
QSPEEMQGAVRDTFQ	FRMPD1	1481	Q5SYB0
MSRSGTDPQQRQQAS	GALT	1	P07902
DEGNSFNSPRNLAME	EIF3D	301	O15371
DPETGNIISLFQAMN	DSP	2341	P15924
FSAIQGDVRSMPDNS	HAP1	86	P54257
IQMGSFRINPDGSQS	CNPY2	51	Q9Y2B0
FRQQFTQLAGPDMEV	CAPNS2	81	Q96L46
AGGTMQPVSDFRQQL	DDX11L8	621	A8MPP1
GNPSSSQVDEEQMNR	FBXW7	21	Q969H0
LQPSQENEMFSIRDS	IL24	151	Q13007
MSFPLDNVDIGFRNQ	DNAJC6	76	O75061
PSQNMFTINSETGDI	CDH4	326	P55283
NDLQSERTPFDGTMV	DHRS12	186	A0PJE2
QQIEDFRQGSETPMQ	CEP85L	326	Q5SZL2
MTLSQEGAQDSFPLQ	CDC6	446	Q99741
VRASTNTMELPDTNG	LUZP1	721	Q86V48
GTVMESNPQQREGSS	MAST4	1911	O15021
SNFTQTVDAPNSMGL	KMT2A	3481	Q03164
EGSQRAEPMFTAVTN	CRTAC1	26	Q9NQ79
PMDGNTTENINDTFI	CYP7A1	116	P22680
MDFEQLQPGDSVIQN	MECR	176	Q9BV79
VSGRSVPADIFQMQA	FBLN5	356	Q9UBX5
MSSRVGDLSPQQQEA	SEC14L4	1	Q9UDX3
FNNRENETILSTSMG	SCNN1G	286	P51170
LSSVFTEMQPIDRNQ	MENT	326	Q9BUN1
FGAQTSSRLSQMQSP	CTU2	406	Q2VPK5
GQLMEPVNRENFTQT	FAM171B	571	Q6P995
GTMFPSNETLNIDND	MCOLN2	171	Q8IZK6
NIDNASPATVSRNGM	DNAH5	2381	Q8TE73
FNPQGFLTAMRQEIT	DNAH5	4486	Q8TE73
NTDMFQIGRSTESPI	PELI1	96	Q96FA3
SPLSEEFLQEMGNIQ	PPARA	21	Q07869
AVMDQEPAGNRTVNS	KIR2DS1	276	Q14954
MFGLDQFEPQVNSRN	MN1	1	Q10571
DNIVITFESGRPDQM	NTNG1	146	Q9Y2I2
TVEAGLMSQASRPEQ	MIDN	101	Q504T8
GRAPVDFINISTDMN	FOXN4	401	Q96NZ1
NGDTSTEEPMLNVQR	MRPS34	181	P82930
SSPENFQRQAVMNSA	RBM7	136	Q9Y580
EAMPLQSNTFQEGTE	PWWP2A	216	Q96N64
PVSRLGDQMFTNGQT	POLR1A	311	O95602
ESENRNGRSPGTQEM	POLR1A	1106	O95602
GIRSNSSPLQQMTFE	POLR1A	1661	O95602
LEFRNSGPLGTEMNT	SRRM2	1331	Q9UQ35
PNSTGSVQNTSRDME	TATDN2	421	Q93075
TRGMTNQSDTDNFPD	TBR1	56	Q16650
LGETPQNLSRGMESF	SPATA31C2	521	B4DYI2
ANAATGDEQVMRNQP	TAB2	391	Q9NYJ8
GDEQVMRNQPTLFIS	TAB2	396	Q9NYJ8
MRNQPTLFISTNSGA	TAB2	401	Q9NYJ8
TEVGENQRAGMQTPF	F5	1886	P12259
MTGFTQRATIDPELN	MKLN1	511	Q9UL63
NTMQESLPSGIVNFR	RIF1	1821	Q5UIP0
AANPEASLANRNSMV	NCOA1	1191	Q15788
FGASQVVSMENNLTP	NEXMIF	916	Q5QGS0
VDMNGSPQDFNVAVR	PRSS23	346	O95084
GMDPNSDDSSRNLFV	SGO1	121	Q5FBB7
NPFAENEESQQRSMR	RAPGEF5	326	Q92565
NMDFSIRIGNITPAD	SIRPA	101	P78324
QQRPTDMSALNNLFG	SCYL2	831	Q6P3W7
QAQDTVEGSNPTMRG	SLC25A41	311	Q8N5S1
LPSQVTEMFNQGRAF	WIPI2	306	Q9Y4P8
EIMALNFNQTPAATG	SLF2	626	Q8IX21
DSGALMANRFVSSPQ	NUP160	806	Q12769
RTFQLGQAMVAEASP	EXTL1	171	Q92935
IRDQDPMLNSNGSVT	SELENOP	36	P49908
PERNSLSAIFNNVMT	SLC29A1	71	Q99808
MPGQANLVRDLQDSF	ARHGAP22	196	Q7Z5H3
RSQPTASAQLENMEE	SNED1	1271	Q8TER0
FESLEPEMNNQASRV	SPTBN1	891	Q01082
RTQETPSAQMEGFLN	SPTBN1	2191	Q01082
TSSLDPNDQVAMGRQ	AATF	476	Q9NY61
QMDPGDFINSSETRL	CLASP2	806	O75122
DQPLDQATISLQMGT	CNN1	196	P51911
MEQSSPGFRQTHLQD	PLEKHS1	181	Q5SXH7
IGAPSADQTLTNMNR	UHRF2	521	Q96PU4
QRFSANSMLTPELQE	PRSS45P	126	Q7RTY3
MSQSQNAIFTSPTGE	TRAK2	1	O60296
NAIFTSPTGEENLMN	TRAK2	6	O60296
GRQMELVSVEAQSSP	STIL	766	Q15468
TMRGPNNATLFTAAE	CSE1L	531	P55060
EENGMENPLLSSQFT	UNC80	3226	Q8N2C7
RTQMVALDGATPFQS	ZP1	486	P60852
QQKVRMANEGFDPST	SLC27A3	636	Q5K4L6
DFNGSANPLMREQSE	SOGA3	626	Q5TF21
SEPTGSVSNRNMERA	RLIM	426	Q9NVW2
DQVGVPRSIAANMTF	POLR2A	376	P24928
AAQSLGEPATQMTLN	POLR2A	1091	P24928
AFQQSGSQSPDSRMS	TBC1D8	456	O95759
QEQEQTAEPLMGSSL	ZNF410	371	Q86VK4
GLMQNTIFVSSPRDE	TBC1D16	556	Q8TBP0
QTSQMAAENIGSELP	TBC1D1	471	Q86TI0
EICTEMLRQFTGNPN	SMOX	446	Q9NWM0
SVGPENFAQMQSFVR	VWA2	541	Q5GFL6
ESILFMGRVTNPDTQ	SERPINI2	381	O75830
TGSMDADVTQTPRNR	TRBV24-1	16	A0A075B6N3
PAVSTDVRFANMLGQ	PRPF40B	521	Q6NWY9
FNSQGSIEATMERPL	USF3	1196	Q68DE3
GNPVSSLRSMQSQAF	USF3	1761	Q68DE3
NQVQTRSADEPMTTF	TCEA3	321	O75764
MDPTGSQLDSDFSQQ	TP53BP1	1	Q12888
QTETDPNNTQMILGA	RALGAPB	671	Q86X10
VNAQTTREANMGTPS	ZSCAN4	161	Q8NAM6
TREANMGTPSQTSQD	ZSCAN4	166	Q8NAM6
NTEMLDNLPSAGSQF	ZIM2	146	Q9NZV7
DGSQMVRSQESLTFQ	ZNF713	21	Q8N859
LVNVNDNRAGMTSSP	ZNF148	771	Q9UQR1
NSSNEVFPQGAEERM	VEZT	676	Q9HBM0
MDPVRQQSGNANTET	WWP1	336	Q9H0M0
NRTFQDEPLIMDFNG	ITFG1	151	Q8TB96
PFNGQMVTEGRSQEE	THSD4	546	Q6ZMP0
NDPNSMFLTGDTAQS	TRANK1	1411	O15050
SFATSTPNNMGLVRN	WDR11	531	Q9BZH6
ATMPRSQSQQRTSAG	TOM1L2	176	Q6ZVM7
YESTPEVSRGNQTMA	PLEKHA5	1071	Q9HAU0
LFNQLMRDDPSTVNG	TRAPPC13	41	A5PLN9
LTDQLMRQTFSPFGQ	TIAL1	216	Q01085
ESKQDESGMPNNRFL	TRBV14	71	A0A5B0
RQLEDPNGSFSNAEM	ZC3H14	571	Q6PJT7
DVMRPLINEQNFDGT	SLC36A4	21	Q6YBV0
TEQLMRQTFSPFGQI	TIA1	226	P31483
GPETLTRFMQEVAAQ	WDR81	131	Q562E7
FSNMGLLSQTEDNPS	TNRC6B	1066	Q9UPQ9
GAPVATNNQSREVAM	SIGLEC16	71	A6NMB1
QTAQGMQLLDPASFE	TYK2	136	P29597
TVAQRSQAPDGMQSL	TYK2	486	P29597
ELMNLGESFIQTNDP	ZFHX3	926	Q15911
MESLRGNTAQGPTNE	ZNF391	1	Q9UJN7
MVSQETSGFPSQRQN	NAF1	401	Q96HR8
TVQGNSMLEDRPTSN	MYO7A	1136	Q13402
RSNAPATLTFENMAG	GRIN1	801	Q05586